Part 2: Biosimilars and Patients with Inflammatory Bowel DiseaseKenneth McQuaid, MD
UCSF School of Medicine

Edward Li, PharmD, MPH, BCOP
University of New England College of Pharmacy

Catherine Bauer, MSN, RN, MBA, CGRN, CFER
University of Virginia Medical Center

Play

Access other Therapeutic Areas:


 

New & Noteworthy